Showing results (181-190 of 189) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
International Journal of Clinical Oncology|November 29, 2020
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)Yoichi Naito, Hiroyuki Aburatani, Toraji Amano, et al.International Journal of Clinical Oncology|May 22, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumorsYoichi Naito, Saori Mishima, Kiwamu Akagi, et al.International Journal of Clinical Oncology|August 20, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third editionSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.International Journal of Clinical Oncology|June 10, 2023
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumorsSaori Mishima, Yoichi Naito, Kiwamu Akagi, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2018
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched studyAkitaka Makiyama, Kenji Kunieda, Masaaki Noguchi, et al.BMC Cancer|October 31, 2023
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from JapanKenji Tsuchihashi, Mamoru Ito, Shuji Arita, et al.European Journal of Cancer (Oxford, England : 1990)|June 12, 2020
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)Daisuke Sakai, Hiroya Taniguchi, Naotoshi Sugimoto, et al.International Journal of Clinical Oncology|January 1, 2022
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1Miyuki Harada, Fuminori Kimura, Yasushi Takai, et al.International Journal of Clinical Oncology|January 13, 2022
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2Akiko Tozawa, Fuminori Kimura, Yasushi Takai, et al.Pageof 19